ACTU

Actuate Therapeutics, Inc. Common stock
ACTU

Overview Fund Activity

10 hedge funds and large institutions have $2.85M invested in Actuate Therapeutics, Inc. Common stock in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AIC
1
AWM Investment Company
New York
$1.04M
2
LCAM
2
Long Corridor Asset Management
Hong Kong
$931K
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$263K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$208K
5
NU
5
Northwestern University
Illinois
$207K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
AIC
1
AWM Investment Company
New York
$1.04M 139,511 +139,511 New
LCAM
2
Long Corridor Asset Management
Hong Kong
$931K 125,000 +125,000 New
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$263K 35,300 +35,300 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$208K 27,893 +27,893 New
NU
5
Northwestern University
Illinois
$207K 27,778 +27,778 New
KLCM
6
KG&L Capital Management
Louisiana
$89.4K 12,000 +12,000 New
Citigroup
7
Citigroup
New York
$81.7K 10,973 +10,973 New
Wells Fargo
8
Wells Fargo
California
$25.3K 3,392 +3,392 New
TRCT
9
Tower Research Capital (TRC)
New York
$2.21K 297 +297 New
Bank of America
10
Bank of America
North Carolina
$171 23 +23 New
CFGS
11
Concourse Financial Group Securities
Alabama
– – – –